tacrolimus ointment
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Dermatitis, Atopic
Conditions
Dermatitis, Atopic
Trial Timeline
Oct 1, 2002 → Feb 1, 2005
NCT ID
NCT00691145About tacrolimus ointment
tacrolimus ointment is a phase 3 stage product being developed by Astellas Pharma for Dermatitis, Atopic. The current trial status is completed. This product is registered under clinical trial identifier NCT00691145. Target conditions include Dermatitis, Atopic.
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (3)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00523952 | Phase 3 | Completed |
| NCT00691262 | Phase 3 | Completed |
| NCT00691145 | Phase 3 | Completed |
Competing Products
20 competing products in Dermatitis, Atopic